{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:26:32Z","timestamp":1787372792768,"version":"build-2736575974"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7609-26","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:10:54Z","timestamp":1787091054000},"source":"Crossref","is-referenced-by-count":0,"title":["Plasma Exchange-Responsive Bulbar Dysfunction in Thymoma-Associated Myasthenia Gravis with Concomitant Lambert-Eaton Myasthenic Syndrome"],"prefix":"10.2169","author":[{"given":"Ryuichiro","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ibaraki Prefectural Central Hospital, Japan"},{"name":"Ibaraki Clinical Education and Training Center, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Saiki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol 21: 176-188, 2022.","DOI":"10.1016\/S1474-4422(21)00297-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Iorio R. Myasthenia gravis: the changing treatment landscape in the era of molecular therapies. Nat Rev Neurol 20: 84-98, 2024.","DOI":"10.1038\/s41582-023-00916-w"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Oh SJ. Myasthenia gravis Lambert-Eaton overlap syndrome. Muscle Nerve 53: 20-26, 2016.","DOI":"10.1002\/mus.24921"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Murai H, Utsugisawa K, Motomura M, Imai T, Uzawa A, Suzuki S. The Japanese Clinical Guidelines 2022 for myasthenia gravis and Lambert-Eaton myasthenic syndrome. Clin Exp Neuroimmunol 14: 19-27, 2023.","DOI":"10.1111\/cen3.12739"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gochi AM, Liang E, Guha S, Velotta JB. Management of stage IVa thymoma with coexistence of Lambert-Eaton myasthenic syndrome and myasthenia gravis in a postpartum female: a case report. AME Case Rep 9: 127, 2025.","DOI":"10.21037\/acr-2025-114"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10: 1098-1107, 2011.","DOI":"10.1016\/S1474-4422(11)70245-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mantegazza R, Meisel A, Sieb JP, Le Masson G, Desnuelle C, Essing M. The European LEMS Registry: baseline demographics and treatment approaches. Neurol Ther 4: 105-124, 2015.","DOI":"10.1007\/s40120-015-0034-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shock A, Humphreys D, Nimmerjahn F. Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: lessons from therapeutic modalities targeting Fcgamma receptors. J Allergy Clin Immunol 146: 492-500, 2020.","DOI":"10.1016\/j.jaci.2020.06.036"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Parisi N, Nadim M, Akgun Y. Mechanisms of immune modulation by therapeutic plasma exchange. Transfus Apher Sci 65: 104371, 2026.","DOI":"10.1016\/j.transci.2026.104371"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87: 419-425, 2016.","DOI":"10.1212\/WNL.0000000000002790"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harimohan H, Yasonova M, Sukkar M, Sabetian K. A rare case of Lambert-Eaton myasthenia syndrome with dysphasia and dysarthria. Cureus 17: e86700, 2025.","DOI":"10.7759\/cureus.86700"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7609-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:10:41Z","timestamp":1787371841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7609-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7609-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7609-26"}}